ArticleeLife2019
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity.
Lucy Chou-Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it
ArticleeLife2019
Lucy Chou-Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.